JP Morgan Maintains Overweight on Praxis Precision Medicine, Raises Price Target to $725

Benzinga · 1d ago
JP Morgan analyst Tessa Romero maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Overweight and raises the price target from $700 to $725.